Literature DB >> 30840880

HNF4α Combinatorial Isoform Heterodimers Activate Distinct Gene Targets that Differ from Their Corresponding Homodimers.

Hui Ling Ko1, Ziyi Zhuo1, Ee Chee Ren2.   

Abstract

Hepatocyte nuclear factor 4α (HNF4α) is a dimeric transcription factor that controls as much as 60% of all liver genes. However, how it achieves such broad functional diversity is unknown. Here, we show that inflammation and immune pathway genes are differentially regulated in an isoform-dependent manner, confirming that each isoform homodimer preferentially regulates a subset of HNF4α targets. With all 12 human HNF4α isoform clones, we tested combinatorial pairings to determine whether isoform heterodimers are functional. Indeed, synergistic and potent pairing combinations of isoform heterodimers were noted for HNF4α3-8, HNF4α6-12, and HNF4α5-8 that activated CYP7A1, IL6, and IL17A genes, respectively. Surprisingly, these genes are not at all activated by their corresponding isoform homodimers, suggesting that a particular heterodimer pair can regulate its own subset of target genes. Given the combinatorial possibility of 66 isoform heterodimers, our data provide the basis for a more detailed understanding of the diverse influence of HNF4α.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HNF4A; HNF4α; NR2A1; differential gene expression; immunity; inflammation; isoform heterodimers; isoform homodimers; nuclear receptors; transcription

Mesh:

Substances:

Year:  2019        PMID: 30840880     DOI: 10.1016/j.celrep.2019.02.033

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  10 in total

1.  Human Hepatocyte Nuclear Factor 4-α Encodes Isoforms with Distinct Transcriptional Functions.

Authors:  Élie Lambert; Jean-Philippe Babeu; Joël Simoneau; Jennifer Raisch; Laurie Lavergne; Dominique Lévesque; Émilie Jolibois; Mariano Avino; Michelle S Scott; François Boudreau; Francois-Michel Boisvert
Journal:  Mol Cell Proteomics       Date:  2020-03-02       Impact factor: 5.911

2.  Angiomotin mutation causes glomerulopathy and renal cysts by upregulating hepatocyte nuclear factor transcriptional activity.

Authors:  Yaochun Zhang; Liangjian Lu; Zhenhua Hu; Yu Dai; Nurul Jannah Binti Ahmad; Jun Li Ng; Chang Yien Chan; Md Zakir Hossain; Alwin Hwai Liang Loh; Jerrold M Ward; Puay Hoon Tan; Sonia Davila; Vikrant Kumar; Walter Hunziker; Haishu Lin; Hui Kim Yap; Kar Hui Ng
Journal:  Clin Transl Med       Date:  2022-06

3.  Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4.

Authors:  Soledad A Camolotto; Veronika K Belova; Luke Torre-Healy; Jeffery M Vahrenkamp; Kristofer C Berrett; Hannah Conway; Jill Shea; Chris Stubben; Richard Moffitt; Jason Gertz; Eric L Snyder
Journal:  Gut       Date:  2020-08-21       Impact factor: 23.059

Review 4.  A Review of Functional Characterization of Single Amino Acid Change Mutations in HNF Transcription Factors in MODY Pathogenesis.

Authors:  Hasan Çubuk; Özlem Yalçın Çapan
Journal:  Protein J       Date:  2021-05-05       Impact factor: 2.371

Review 5.  Therapeutic Potential of HNF4α in End-stage Liver Disease.

Authors:  Ricardo Diaz-Aragon; Michael C Coard; Sriram Amirneni; Lanuza Faccioli; Nils Haep; Michelle R Malizio; Takashi Motomura; Zehra N Kocas-Kilicarslan; Alina Ostrowska; Rodrigo M Florentino; Carla Frau
Journal:  Organogenesis       Date:  2021-10-02       Impact factor: 2.316

6.  Saikosaponin C exerts anti-HBV effects by attenuating HNF1α and HNF4α expression to suppress HBV pgRNA synthesis.

Authors:  Yanchao Pan; Zhiyi Ke; Hong Ye; Lina Sun; Xiaoyan Ding; Yun Shen; Runze Zhang; Jing Yuan
Journal:  Inflamm Res       Date:  2019-09-17       Impact factor: 4.575

7.  Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis.

Authors:  Zhen Ni; Wenquan Lu; Qi Li; Chuan Han; Ting Yuan; Nina Sun; Yongquan Shi
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

8.  HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.

Authors:  Huajie Song; Dan Li; Xiaojing Wang; Erhu Fang; Feng Yang; Anpei Hu; Jianqun Wang; Yanhua Guo; Yang Liu; Hongjun Li; Yajun Chen; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  J Hematol Oncol       Date:  2020-03-26       Impact factor: 17.388

Review 9.  Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology.

Authors:  Vanessa Dubois; Bart Staels; Philippe Lefebvre; Michael P Verzi; Jérôme Eeckhoute
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

Review 10.  Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease.

Authors:  Yang Xiao; Mindy Kim; Mitchell A Lazar
Journal:  Mol Metab       Date:  2020-11-18       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.